GB9201755D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB9201755D0 GB9201755D0 GB929201755A GB9201755A GB9201755D0 GB 9201755 D0 GB9201755 D0 GB 9201755D0 GB 929201755 A GB929201755 A GB 929201755A GB 9201755 A GB9201755 A GB 9201755A GB 9201755 D0 GB9201755 D0 GB 9201755D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201755A GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
| AU33639/93A AU3363993A (en) | 1992-01-28 | 1993-01-27 | Amino acid derivatives as PAF antagonists |
| PCT/GB1993/000167 WO1993015047A1 (en) | 1992-01-28 | 1993-01-27 | Amino acid derivatives as paf antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201755A GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9201755D0 true GB9201755D0 (en) | 1992-03-11 |
Family
ID=10709355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929201755A Pending GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU3363993A (en) |
| GB (1) | GB9201755D0 (en) |
| WO (1) | WO1993015047A1 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| US10640563B2 (en) | 2016-06-08 | 2020-05-05 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
| EP4530296A2 (en) | 2016-04-27 | 2025-04-02 | AbbVie Manufacturing Management Unlimited Company | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4327256A1 (en) * | 1993-08-13 | 1995-02-16 | Bayer Ag | Sulfonylbenzyl-substituted benzimidazoles, process for their preparation and their use in medicaments |
| US5824696A (en) * | 1993-09-01 | 1998-10-20 | Smithkline Beecham Corporation | Medicaments |
| US5756548A (en) * | 1995-04-03 | 1998-05-26 | Centaur Pharmaceuticals, Inc. | Acetamidobenzamide compounds for neurodegenerative disorders |
| US5955506A (en) * | 1996-04-03 | 1999-09-21 | Centaur Pharmaceuticals, Inc. | Benzamides for neurodegenerative disorder treatment |
| DE69833858T2 (en) | 1997-07-08 | 2007-02-22 | Ono Pharmaceutical Co. Ltd. | AMINO ACID DERIVATIVES |
| TWI245035B (en) | 1998-06-26 | 2005-12-11 | Ono Pharmaceutical Co | Amino acid derivatives and a pharmaceutical composition comprising the derivatives |
| KR100633349B1 (en) | 1998-07-14 | 2006-10-16 | 오노 야꾸힝 고교 가부시키가이샤 | Amino acid derivatives and drugs containing them as active ingredients |
| SE0000382D0 (en) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
| US6706712B2 (en) | 2000-12-20 | 2004-03-16 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
| CA2432908A1 (en) | 2000-12-20 | 2002-06-27 | Bristol-Myers Squibb Pharma Company | Diamines as modulators of chemokine receptor activity |
| WO2002060388A2 (en) | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| PL373043A1 (en) | 2002-03-26 | 2005-08-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| US7037936B2 (en) | 2002-06-17 | 2006-05-02 | Signal Pharmaceuticals, Llc. | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| TW200510305A (en) | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| UY28526A1 (en) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME |
| US7291744B2 (en) | 2003-11-13 | 2007-11-06 | Bristol-Myers Squibb Company | N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
| US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| NZ553646A (en) | 2004-09-22 | 2010-07-30 | Janssen Pharmaceutica Nv | Inhibitors of the interaction between MDM2 and p53 |
| DE602005015027D1 (en) | 2004-12-27 | 2009-07-30 | Boehringer Ingelheim Pharma | GLUCOCORTICOID MIMETICS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND THEIR USE |
| CA2671990A1 (en) | 2006-12-06 | 2008-06-12 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| UY30892A1 (en) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | AKT ACTIVITY INHIBITORS |
| CA2982520A1 (en) * | 2007-08-21 | 2009-02-26 | Senomyx, Inc. | Identification of human t2r receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof |
| CA2726449A1 (en) | 2008-06-06 | 2009-12-10 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| CA3113233A1 (en) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904174D0 (en) * | 1989-02-23 | 1989-04-05 | British Bio Technology | Compounds |
| IE70217B1 (en) * | 1990-08-15 | 1996-10-30 | British Bio Technology | Benzimidazole derivatives process for their preparation and application |
| PT98674B (en) * | 1990-08-15 | 1999-01-29 | British Bio Technology | METHOD FOR THE PREPARATION OF COMPOUNDS THAT ARE ANTAGONISTS OF THE ACTIVATION FACTOR OF PLATELETS FOR EXAMPLE DERIVATIVES OF IMIDAZOLE AND OF THEIR INTERMEDIARIES |
| GB9107398D0 (en) * | 1991-04-09 | 1991-05-22 | British Bio Technology | Compounds |
-
1992
- 1992-01-28 GB GB929201755A patent/GB9201755D0/en active Pending
-
1993
- 1993-01-27 AU AU33639/93A patent/AU3363993A/en not_active Abandoned
- 1993-01-27 WO PCT/GB1993/000167 patent/WO1993015047A1/en active Application Filing
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| EP4530296A2 (en) | 2016-04-27 | 2025-04-02 | AbbVie Manufacturing Management Unlimited Company | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| US10640563B2 (en) | 2016-06-08 | 2020-05-05 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3363993A (en) | 1993-09-01 |
| WO1993015047A1 (en) | 1993-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300508A0 (en) | Compounds | |
| GB9209628D0 (en) | Compounds | |
| GB9200245D0 (en) | Compounds | |
| GB9201755D0 (en) | Compounds | |
| GB9200210D0 (en) | Compounds | |
| GB9201694D0 (en) | Compounds | |
| GB9200209D0 (en) | Compounds | |
| GB9201693D0 (en) | Compounds | |
| GB9210632D0 (en) | Compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9201692D0 (en) | Compounds | |
| GB9205859D0 (en) | Compounds | |
| GB9207966D0 (en) | Compounds | |
| GB9204684D0 (en) | Compounds | |
| GB9201819D0 (en) | Compounds | |
| GB9201748D0 (en) | Compounds | |
| GB9202827D0 (en) | Compounds | |
| GB9202991D0 (en) | Compounds | |
| GB9203169D0 (en) | Compounds | |
| GB9203170D0 (en) | Compounds | |
| GB9203171D0 (en) | Compounds | |
| GB9203172D0 (en) | Compounds | |
| GB9208859D0 (en) | Compounds |